Antibiotics stewardship 2026
Reading File
Finding Sources
Searching PubMed
"antibiotic stewardship" AND outcomes
Searching the Web
antibiotic stewardship 2025 2026 guidelines WHO CDC updates
Reading File
Reading File
Reading Web Page
https://www.cdc.gov/antibiotic-use/hcp/data-research/steward…
Reading File
Searching PubMed
"antimicrobial stewardship" AND "prospective audit" AND outcomes
Here is a comprehensive overview of antibiotic stewardship as of 2026, drawing from Harrison's Principles of Internal Medicine (22nd ed.), The Harriet Lane Handbook (23rd ed.), CDC's 2026 update, and recent peer-reviewed evidence.
Antibiotic Stewardship - 2026
What Is It?
Antibiotic stewardship (AS) is the coordinated effort to ensure antibiotics are prescribed and used only when they provide a clear health benefit - the right drug, right dose, right route, and right duration for the right patient. It is the primary clinical strategy to combat antimicrobial resistance (AMR), which is a leading cause of morbidity and mortality globally.
Why It Matters Now
- Antibiotic resistance is a growing public health threat responsible for increasing morbidity and mortality in both adults and children (Harriet Lane Handbook, p. 632).
- Ambulatory (outpatient) antibiotic use accounts for ~85% of all antibiotic use in most developed countries - making outpatient stewardship at least as important as hospital stewardship (Harrison's, p. 296).
- AMR pathogens like MRSA, ESBL-producers, CRE, and VRE are increasing in frequency and treatment complexity.
CDC Core Elements Framework (2026 Update)
The CDC published the original Core Elements of Hospital Antibiotic Stewardship in 2014. As of February 9, 2026, the CDC released its updated annual report and announced a 2026 revision to the Outpatient Core Elements, with a new focus on health system leadership.
7 Core Elements (Hospital Setting)
| Element | Description |
|---|---|
| 1. Leadership Support | Executive buy-in, dedicated resources, accountability |
| 2. Accountability | Designated physician leader responsible for stewardship outcomes |
| 3. Pharmacy Expertise | ID pharmacist or physician expert in antibiotic use |
| 4. Action | Priority interventions (see below) |
| 5. Tracking | Monitor antibiotic prescribing, resistance, outcomes |
| 6. Reporting | Provide regular data feedback to clinical providers |
| 7. Education | Ongoing training for clinicians, staff, and patients |
4 Core Elements (Outpatient Setting, per CDC 2016; 2026 revision underway)
- Commit to improving antibiotic prescribing
- Implement at least one policy or intervention and assess effectiveness
- Monitor prescribing and provide feedback
- Provide educational resources to clinicians and patients
The 2026 update shifts outpatient Core Elements to emphasize health system leadership - enabling health systems to disseminate guidelines, embed clinical decision support into EHRs, and standardize stewardship across networks including low-resource and rural outpatient settings (CDC, Feb. 2026).
Priority Interventions (What ASPs Actually Do)
1. Prospective Audit and Feedback (PAF)
The CDC now designates PAF as a priority intervention. An ID pharmacist or ID physician (not part of the treating team) reviews antibiotic therapy and provides real-time optimization suggestions. Handshake stewardship - face-to-face discussions between the ASP team and treating providers - enhances effectiveness.
2. Prior Authorization / Formulary Restriction
Requiring approval before dispensing certain broad-spectrum antibiotics (e.g., carbapenems, daptomycin). Highly effective but resource-intensive.
3. Facility-Specific Treatment Guidelines
Protocols based on the local antibiogram - the "antibiogram-based" approach. Local resistance patterns must guide empiric therapy.
4. Antibiotic Timeout
A provider-led pause at 48-72 hours of therapy to reassess: is the diagnosis correct? Is culture data available? Can therapy be narrowed, stopped, or de-escalated? Now classified as a supplemental (not primary) intervention per the CDC.
5. Clinical Decision Support
EHR-embedded alerts, dose optimization tools, and guideline prompts. The 2026 CDC update specifically highlights CDS integration as a key mechanism for outpatient stewardship at scale.
Effective Outpatient Strategies
From Harrison's (22nd ed., p. 296-297), the following interventions have evidence for reducing inappropriate outpatient antibiotic prescribing:
| Intervention | Evidence |
|---|---|
| Peer comparison (showing prescribers their rates vs. peers) | Strong |
| Accountable justification (requiring reason in EHR) | Strong |
| Precommitment (pledging to follow guidelines) | Moderate |
| Communication training | Strong (especially with clear diagnosis, expected course, red flags) |
| Patient education | Moderate |
| Telemedicine | Promising for reducing inappropriate prescribing |
| Procalcitonin testing | NOT proven effective for outpatient stewardship |
| CRP testing | Not durable |
| Delayed antibiotic prescriptions | Should be avoided - conceptually flawed, shifts clinical decision-making to patients, sends mixed messages |
Resistance Patterns Driving Stewardship (2026)
From the Harriet Lane Handbook (23rd ed.), key resistance issues shaping current stewardship:
Gram-Positive
- MRSA: TMP-SMX remains >90% susceptible; clindamycin up to 40% resistant in some regions. Vancomycin preferred for bacteremia, endocarditis, and meningitis; linezolid as alternative.
- Group A Strep: Penicillin/amoxicillin remain drugs of choice. Macrolide resistance ~5% nationally.
- VRE (E. faecium): Increasing in pediatrics - empiric daptomycin or linezolid.
Gram-Negative
- ESBL-producers (E. coli, Klebsiella): Carbapenems are drugs of choice; piperacillin/tazobactam is inferior.
- CRE (Carbapenem-Resistant Enterobacterales): Treatment options include ceftazidime/avibactam, meropenem/vaborbactam, imipenem/cilastatin/relebactam, and cefiderocol. Extended meropenem infusion may be considered in specific scenarios.
- AmpC-producers: Risk of resistance induction with some cephalosporins.
AI in Antibiotic Stewardship (Emerging 2025-2026)
A 2025 systematic review (PMID: 39955846, Artificial Intelligence in Medicine) found that AI-driven tools are increasingly integrated into ASPs to optimize prescription practices - including machine learning models for predicting resistance, CDS alerts, and automated audit tools. This is an actively evolving area.
Emerging Settings for Stewardship
- Skilled Nursing Facilities (SNFs): A Pennsylvania survey (2024-2025) found ~79% of SNFs report antibiotic use data to providers, but most still rely on manual Excel tracking. Expanded software infrastructure and training are key gaps.
- Correctional facilities: NCCHC released a 2026 position statement highlighting that carceral systems have a critical opportunity to implement ASPs, given high-density living and the connection to community health ecosystems.
- Dental settings: A 2025 systematic review (PMID: 39400429) assessed dental antibiotic stewardship interventions - a historically under-addressed prescribing context.
Procalcitonin and Pneumonia (2026 Evidence Update)
A 2026 systematic review (PMID: 41412284, Am J Med Sci) examined procalcitonin-guided pneumonia management in European vs. US settings and found heterogeneous outcomes - procalcitonin-based stewardship works better in some systems than others. This reinforces the Harrison's caution that procalcitonin is "not proven" as a standalone outpatient stewardship tool, though it may have a more defined role in hospital/ICU settings.
Summary: The Stewardship Formula
Right drug + Right dose + Right route + Right duration + Right patient = Antibiotic Stewardship
Effective programs combine structural elements (leadership, accountability, pharmacy expertise), targeted interventions (PAF, formulary control, CDS), measurement (antibiograms, prescribing data), and education - all tailored to the healthcare setting. The 2026 trend is toward health system-level integration, AI-assisted decision support, and expanding stewardship beyond hospitals into outpatient, dental, SNF, and correctional settings.
This is a shared conversation. Sign in to Orris to start your own chat.